Medicare Enrolled

Dr. Roman Czubatyj, M.D.

Rheumatology · Rochester Hills, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1701 SOUTH BLVD E STE 110, Rochester Hills, MI 48307
2488530803
Registered in NPPES since 2007
NPI: 1972797892 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Czubatyj from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Czubatyj? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Czubatyj

Dr. Roman Czubatyj is a rheumatology specialist in Rochester Hills, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Czubatyj performed 29,680 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Czubatyj received a total of $688,606 from 36 pharmaceutical and/or device companies across 1713 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Czubatyj is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 11% volume in MI $688,606 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
29,680
Medicare services
Top 11% in MI for rheumatology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
28,800 $11 $29
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
292 $97 $345
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
169 $86 $269
New patient office visit, complex (60-74 min) 146 $168 $521
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
89 $21 $110
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
80 $12 $85
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
68 $3 $20
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $65 $184
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
12 $8 $64
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
98.0% high complexity
0.8% medium
1.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$688,606
Total received (2018-2024)
Avg $98,372/year across 7 years
Top 2% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
1,713
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$184,063
2023
$156,302
2022
$111,051
2021
$59,532
2020
$47,454
2019
$69,945
2018
$60,258

Payments by company (2024)

Amgen Inc.
$140,850
Janssen Biotech, Inc.
$24,035
ABBVIE INC.
$18,093
Novartis Pharmaceuticals Corporation
$257
GlaxoSmithKline, LLC.
$159
Lilly USA, LLC
$141
UCB, Inc.
$141
E.R. Squibb & Sons, L.L.C.
$91
Fresenius Kabi USA, LLC
$54
Sandoz Inc.
$46
Cardinal Health Inc
$43
PFIZER INC.
$40
GENZYME CORPORATION
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
AstraZeneca Pharmaceuticals LP
$23
Genentech USA, Inc.
$20
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$287,849
Amgen Inc.
$200,250
Janssen Biotech, Inc.
$43,173
ABBVIE INC.
$43,093
Horizon Pharma plc
$37,484
AbbVie Inc.
$37,076
Janssen Scientific Affairs, LLC
$17,781
AbbVie, Inc.
$12,498
GENZYME CORPORATION
$4,722
Novartis Pharmaceuticals Corporation
$956
PFIZER INC.
$661
Lilly USA, LLC
$584
UCB, Inc.
$506
GlaxoSmithKline, LLC.
$367
E.R. Squibb & Sons, L.L.C.
$360
Flexion Therapeutics, Inc.
$204
Genentech USA, Inc.
$134
Sandoz Inc.
$124
intraFUSION GP, LLC
$110
Celgene Corporation
$82
AstraZeneca Pharmaceuticals LP
$81
SANOFI-AVENTIS U.S. LLC
$65
Antares Pharma, Inc.
$62
Fresenius Kabi USA, LLC
$54
Ferring Pharmaceuticals Inc.
$44
Cardinal Health Inc
$43
Regeneron Healthcare Solutions, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Hikma Pharmaceuticals USA
$29
Sobi, Inc
$28
Organon LLC
$27
Bioventus LLC
$24
Alexion Pharmaceuticals, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$19
Merck Sharp & Dohme Corporation
$16
Arcutis Biotherapeutics, Inc.
$15
Top 3 companies account for 77.2% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Access · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · EUFLEXXA · Enbrel · GELSYN 3 · GELSYN-3 · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LYRICA · Mitigare · NO PRODUCT DISCUSSED · NUCALA · ORENCIA · Otezla · Otrexup · PENNSAID · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Tavneos · UPLIZNA · VIMOVO · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Rochester Hills?
Compare rheumatologists in the Rochester Hills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
59
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Czubatyj is a mixed practice specialist, with above-average Medicare volume (top 11% in MI), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Czubatyj experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Czubatyj performed 28,800 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Czubatyj receive payments from pharmaceutical companies?
Yes. Dr. Czubatyj received a total of $688,606 from 36 companies across 1,713 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Czubatyj's costs compare to other rheumatologists in Rochester Hills?
Dr. Czubatyj's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Czubatyj) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →